Top : For Professionals Only : Antibiotics

CF Resources: For Professionals Only : Antibiotics

Home | Add a Site | What's New | Email Updates | Random Link | Search

Links:

  • Macrolide Antibiotics and Cystic Fibrosis (2002) - Synergistic Activities of Macrolide Antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans Isolated from Patients with Cystic Fibrosis (Added: 23-Oct-2002 Hits: 137 Rating: 0 ) Rate It
  • Tobi Approved In Canada For Cystic Fibrosis (1999) - Health Canada’s Therapeutic Products Programme has approved PathoGenesis Canada Ltd.’s Tobi(TM) (tobramycin solution for inhalation) for the management of cystic fibrosis (CF) patients with chronic pulmonary Pseudomonas aeruginosa infections. (Added: 2-Dec-2002 Hits: 180 Rating: 0 ) Rate It
  • Tobi Can Save Money For Canadian CF Patients (1999) - June 11, 1999 -- Results of a Canadian cystic fibrosis study show that Tobi (tobramycin solution for inhalation) can save $4,055 CDN per patient in a 24-week period compared to patients who are not receiving nebulised antibiotics. (Canada) (Added: 23-Oct-2002 Hits: 188 Rating: 0 ) Rate It

Search

Looking for something in particular?
More search options

Pages Updated On: 2-Sep-2009 - 15:28:35
Links Engine 2.0 By: Gossamer Threads Inc.



Cystic Fibrosis-Reaching Out Foundation, Inc.
PO Box 870747
Stone Mountain, GA 30087
770-381-3710
770-564-2331 FAX
info@ReachingOutFoundation.org
www.ReachingOutFoundation.org

The Cystic Fibrosis-Reaching Out Foundation is a non-profit Foundation under Section 501 (c) 3 of the Internal Revenue Code. Accordingly, the Foundation is not required to pay income taxes. Donors may deduct contributions to the Cystic Fibrosis-Reaching Out Foundation Inc, only to the extent that their contributions are gifts, with no consideration given.